Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
Hope for hacking cough: new pill shows promise in clinical trial
Symptom relief CompletedThis study tested a new tablet called nalbuphine ER for people with a long-lasting cough that doesn't get better with treatment. 66 adults with refractory chronic cough took the drug or a placebo to see if it reduced coughing. The goal was to measure cough frequency and check for…
Phase: PHASE2 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC
-
Healthy volunteers help test drug safety combo
Knowledge-focused CompletedThis study looked at how a long-acting painkiller (nalbuphine ER) interacts with two lung fibrosis drugs (pirfenidone and nintedanib) in 132 healthy adults. Researchers measured drug levels in the blood and checked for side effects. The goal was to see if these drugs can be safel…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Liver function may change how itch drug works in body
Knowledge-focused CompletedThis early-phase study looked at how the drug nalbuphine extended-release is processed in people with mild, moderate, or severe liver problems compared to those with healthy livers. It also explored whether the drug could help relieve itching in participants who reported it. The …
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated May 08, 2026 12:04 UTC